Bio-Rad Reports First-Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Bio-Rad Labs (BIO) Tops Q1 EPS by $1.54
April 28, 2022 4:21 PM EDTBio-Rad Labs (NYSE: BIO) reported Q1 EPS of $4.94, $1.54 better than the analyst estimate of $3.40. Revenue for the quarter came in at $700 million versus the consensus estimate of $675.1 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
... More